Estimating the therapeutic potential of NSAIDs and linoleic acid-isomers supplementation against neuroinflammation

Carla Paulo Vieira,Carini A Lelis,Alan Clavelland Ochioni,Denes Kaic A Rosário,Iuri L S Rosario,Italo Rennan S Vieira,Anna Paula A Carvalho,José Marcos Janeiro,Marion P da Costa,Flavia R S Lima,Rafael M Mariante,Luiz Anastácio Alves,Debora Foguel,Carlos Adam Conte Junior
DOI: https://doi.org/10.1016/j.biopha.2024.116884
Abstract:Nonsteroidal anti-inflammatory drugs (NSAIDs) regulate inflammation, which is associated with their role in preventing neurodegenerative diseases in epidemiological studies. It has sparked interest in their unconventional application for reducing neuroinflammation, opening up new avenues in biomedical research. However, given the pharmacological drawbacks of NSAIDs, the development of formulations with naturally antioxidant/anti-inflammatory dietary fatty acids has been demonstrated to be advantageous for the clinical translation of anti-inflammatory-based therapies. It includes improved blood-brain barrier (BBB) permeability and reduced toxicity. It permits us to speculate about the value of linoleic acid (LA)-isomers in preventing and treating neuroinflammatory diseases compared to NSAIDs. Our research delved into the impact of various factors, such as administration route, dosage, timing of intervention, and BBB permeability, on the efficacy of NSAIDs and LA-isomers in preclinical and clinical settings. We conducted a systematic comparison between NSAIDs and LA-isomers regarding their therapeutic effectiveness, BBB compatibility, and side effects. Additionally, we explored their underlying mechanisms in addressing neuroinflammation. Through our analysis, we've identified challenges and drawn conclusions that could propel advancements in treating neurodegenerative diseases and inform the development of future alternative therapeutic strategies.
What problem does this paper attempt to address?